Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1975 Nov;56(5):1271–1279. doi: 10.1172/JCI108203

Stimulation of monocyte cGMP by leukocyte dialysates. An antigen-independent property of dialyzable transfer factor.

J A Sandler, T K Smith, V C Manganiello, C H Kirkpatrick
PMCID: PMC301990  PMID: 171284

Abstract

We studied the effects of dialysates from leukocyte lysates containing dialyzable transfer factor activity and other leukocyte dialysates devoid of transfer factor activity on accumulation of cyclic nucleotides in human leukocytes. Dialysates from normal leukocytes produced 4- to 11-fold increases in leukocyte cGMP, and experiments with purified cell populations revealed that the increases were predominantly, if not entirely, in blood monocytes. Substances that increased monocyte cGMP could be obtained from several cell populations including mononuclear cells from Hypaque-Ficoll gradients, plastic-adherent monocytes, nonadherent lymphocytes, and neutrophils, but were not present in dialysates of leukemic lymphocytes from patients with the Sezary syndrome. Moreover, dialysates that increased leukocyte cGMP had essentially no effect on intracellular cAMP. Dialysates of lysed mononuclear cells contained serotonin, ascorbate, and an unidentified cholinergic activity, agents known to increase leukocyte cGMP. After passage of dialyzable transfer factor from mononuclear cells through a gel-filtration column, four fractions were obtained that increased leukocyte cGMP. Two of these fractions contained ascorbate; two other active fractions, including one that also caused conversion of delayed skin tests, did not contain detectable ascorbate or serotonin. The dialysate of lysed neutrophils also increased cGMP, but this activity was limited to the column fractions which contained ascorbic acid. These observations raise the possibility that alterations in monocyte cGMP content could modulate either the specific antigen-dependent, or, more likely, the antigen-independent activities in preparations of transfer factor.

Full text

PDF
1271

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bloom B. R. Does transfer factor act specifically or as an immunologic adjuvant? N Engl J Med. 1973 Apr 26;288(17):908–909. doi: 10.1056/NEJM197304262881712. [DOI] [PubMed] [Google Scholar]
  2. Catanzaro A., Spitler L., Moser K. M. Immunotherapy of coccidioidomycosis. J Clin Invest. 1974 Sep;54(3):690–701. doi: 10.1172/JCI107807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dupont B., Ballow M., Hansen J. A., Quick C., Yunis E. J., Good R. A. Effect of transfer factor therapy on mixed lymphocyte culture reactivity. Proc Natl Acad Sci U S A. 1974 Mar;71(3):867–871. doi: 10.1073/pnas.71.3.867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Edelson R. L., Kirkpatrick C. H., Shevach E. M., Schein P. S., Smith R. W., Green I., Lutzner M. Preferential cutaneous infiltration by neoplastic thymus-derived lymphocytes. Morphologic and functional studies. Ann Intern Med. 1974 Jun;80(6):685–692. doi: 10.7326/0003-4819-80-6-685. [DOI] [PubMed] [Google Scholar]
  5. Estensen R. D., Hill H. R., Quie P. G., Gogan N., Goldberg N. D. Cyclic GMP and cell movement. Nature. 1973 Oct 26;245(5426):458–460. doi: 10.1038/245458a0. [DOI] [PubMed] [Google Scholar]
  6. Gallin J. I., Kirkpatrick C. H. Chemotactic activity in dialyzable transfer factor. Proc Natl Acad Sci U S A. 1974 Feb;71(2):498–502. doi: 10.1073/pnas.71.2.498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gilman A. G. A protein binding assay for adenosine 3':5'-cyclic monophosphate. Proc Natl Acad Sci U S A. 1970 Sep;67(1):305–312. doi: 10.1073/pnas.67.1.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Goetzl E. J., Wasserman S. I., Gigli I., Austen K. F. Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid. J Clin Invest. 1974 Mar;53(3):813–818. doi: 10.1172/JCI107620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Goldberg N. D., O'Dea R. F., Haddox M. K. Cyclic GMP. Adv Cyclic Nucleotide Res. 1973;3:155–223. [PubMed] [Google Scholar]
  10. Griscelli C., Revillard J. P., Betuel H., Herzog C., Touraine J. L. Transfer factor therapy in immuno-deficiencies. Biomedicine. 1973 May;18(3):220–227. [PubMed] [Google Scholar]
  11. Henney C. S., Lichtenstein L. M., Gillespie E., Rolley R. T. In vivo suppression of the immune response to alloantigen by cholera enterotoxin. J Clin Invest. 1973 Nov;52(11):2853–2857. doi: 10.1172/JCI107481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ignarro L. J., George W. J. Hormonal control of lysosomal enzyme release from human neutrophils: elevation of cyclic nucleotide levels by autonomic neurohormones. Proc Natl Acad Sci U S A. 1974 May;71(5):2027–2031. doi: 10.1073/pnas.71.5.2027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. JENSEN K., PATNODE R. A., TOWNSLEY H. C., CUMMINGS M. M. Multiple passive transfer of the delayed type of hypersensitivity in humans. Am Rev Respir Dis. 1962 Mar;85:373–377. doi: 10.1164/arrd.1962.85.3.373. [DOI] [PubMed] [Google Scholar]
  14. Kaliner M., Orange R. P., Austen K. F. Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. J Exp Med. 1972 Sep 1;136(3):556–567. doi: 10.1084/jem.136.3.556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Khan A., Hill J. M., Loeb E., MacLellan A., Hill N. O. Management of Chédiak-Higashi syndrome with transfer factor. Am J Dis Child. 1973 Dec;126(6):797–799. doi: 10.1001/archpedi.1973.02110190643012. [DOI] [PubMed] [Google Scholar]
  16. Kirkpatrick C. H., Rich R. R., Smith T. K. Effect of transfer factor on lymphocyte function in anergic patients. J Clin Invest. 1972 Nov;51(11):2948–2958. doi: 10.1172/JCI107119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. LAWRENCE H. S., PAPPENHEIMER A. M., Jr Transfer of delayed hypersensitivity to diphtheria toxin in man. J Exp Med. 1956 Sep 1;104(3):321–335. doi: 10.1084/jem.104.3.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. LAWRENCE H. S., RAPAPORT F. T., CONVERSE J. M., TILLETT W. S. Transfer of delayed hypersensitivity to skin homografts with leukocyte extracts in man. J Clin Invest. 1960 Jan;39:185–198. doi: 10.1172/JCI104018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lawrence H. S. Transfer factor. Adv Immunol. 1969;11:195–266. doi: 10.1016/s0065-2776(08)60480-0. [DOI] [PubMed] [Google Scholar]
  20. Levin A. S., Byers V. S., Fudenberg H. H., Wybran J., Hackett A. J., Johnston J. O., Spitler L. E. Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor. J Clin Invest. 1975 Mar;55(3):487–499. doi: 10.1172/JCI107955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lichtenstein L. M., Henney C. S., Bourne H. R., Greenough W. B., 3rd Effects of cholera toxin on in vitro models of immediate and delayed hypersensitivity. Further evidence for the role of cyclic adenosine 3',5'-monophosphate. J Clin Invest. 1973 Mar;52(3):691–697. doi: 10.1172/JCI107230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. LoBuglio A. F., Neidhart J. A., Hilberg R. W., Metz E. N., Balcerzak S. P. The effect of transfer factor therapy on tumor immunity in alveolar soft part sarcoma. Cell Immunol. 1973 Apr;7(1):159–165. doi: 10.1016/0008-8749(73)90192-5. [DOI] [PubMed] [Google Scholar]
  23. MAURER P. H. Immunologic studies with ethylene oxide-treated human serum. J Exp Med. 1961 Jun 1;113:1029–1039. doi: 10.1084/jem.113.6.1029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Manganiello V., Evans W. H., Stossel T. P., Mason R. J., Vaughan M. The effect of polystyrene beads on cyclic 3',5'-adenosine monophosphate concentration in leukocytes. J Clin Invest. 1971 Dec;50(12):2741–2744. doi: 10.1172/JCI106775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mozes E., Shearer G. M., Melmon K. L., Bourne H. R. In vitro correction of antigen-induced immune suppression: effects of poly(A) poly(U) and prostaglandin E. Cell Immunol. 1973 Nov;9(2):226–233. doi: 10.1016/0008-8749(73)90073-7. [DOI] [PubMed] [Google Scholar]
  26. Orange R. P., Austen W. G., Austen K. F. Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3',5'-adenosine monophosphate. J Exp Med. 1971 Sep 1;134(3 Pt 2):136s–148s. [PubMed] [Google Scholar]
  27. RAPAPORT F. T., LAWRENCE H. S., MILLAR J. W., PAPPAGIANIS D., SMITH C. E. Transfer of delayed hypersensitivity to coccidioidin in man. J Immunol. 1960 Apr;84:358–367. [PubMed] [Google Scholar]
  28. Sandler J. A., Clyman R. I., Manganiello V. C., Vaughan M. The effect of serotonin (5-hydroxytryptamine) and derivatives on guanosine 3',5'-monophosphate in human monocytes. J Clin Invest. 1975 Feb;55(2):431–435. doi: 10.1172/JCI107948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Spitler L. E., Levin A. S., Stites D. P., Fudenberg H. H., Pirofsky B., August C. S., Stiehm E. R., Hitzig W. H., Gatti R. A. The Wiskott-Aldrich syndrome. Results of transfer factor therapy. J Clin Invest. 1972 Dec;51(12):3216–3224. doi: 10.1172/JCI107148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Strom T. B., Carpenter C. B., Garovoy M. R., Austen K. F., Merrill J. P., Kaliner M. The modulating influence of cyclic nucleotides upon lymphocyte-mediated cytotoxicity. J Exp Med. 1973 Aug 1;138(2):381–393. doi: 10.1084/jem.138.2.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Watson J., Epstein R., Cohn M. Cyclic nucleotides as intracellular mediators of the expression of antigen-sensitive cells. Nature. 1973 Dec 14;246(5433):405–409. doi: 10.1038/246405a0. [DOI] [PubMed] [Google Scholar]
  32. Zuckerman K. S., Neidhart J. A., Balcerzak S. P., LoBuglio A. F. Immunologic specificity of transfer factor. J Clin Invest. 1974 Oct;54(4):997–1000. doi: 10.1172/JCI107841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Zurier R. B., Weissmann G., Hoffstein S., Kammerman S., Tai H. H. Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function. J Clin Invest. 1974 Jan;53(1):297–309. doi: 10.1172/JCI107550. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES